Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Status: Unknown

Conditions: Gastroesophageal Reflux Disease

Study type: Observational

Funder types: Other

Identifiers

NCT00498082

UCL-STLUC-GAS-01

Details and patient eligibility

About

EsophyX is a promising endoscopic treatment for gastro-esophageal reflux disease. It is not known whether there are some pre- or per-operative anatomic or pathophysiological findings which may influence outcome.

The aim of this trial is to study a series of parameters acquired during the pre-therapeutic work-up or during the procedure and their influence on the outcome of the procedure.

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients being considered for EsophyX treatment of GERD